ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 665,36
1,23%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Connect Biopharma Holdings Inc (CNTB)

  7. Connect Biopharma Holdings Inc (CNTB) Actualités

CNTB

Connect Biopharma (CNTB)

Connect Biopharma Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CNTB
DateHeureSourceTitreSymboleSociété
28/02/202403h00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CNTBConnect Biopharma Holdings Inc
13/02/202422h30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:CNTBConnect Biopharma Holdings Inc
13/02/202422h27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CNTBConnect Biopharma Holdings Inc
12/02/202422h50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
23/06/202322h32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTBConnect Biopharma Holdings Inc
11/04/202322h59Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CNTBConnect Biopharma Holdings Inc
11/04/202322h05GlobeNewswire Inc.Connect Biopharma Reports Full Year 2022 Financial Results and Provides Business UpdateNASDAQ:CNTBConnect Biopharma Holdings Inc
18/03/202319h40Business WireConnect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient SymptomsNASDAQ:CNTBConnect Biopharma Holdings Inc
17/03/202321h05Business WireConnect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body RegionsNASDAQ:CNTBConnect Biopharma Holdings Inc
06/03/202314h15Business WireConnect Biopharma CBP-201 Atopic Dermatitis Abstracts from Two Trials Accepted for Presentation at the American Academy of Dermatology (AAD) Annual MeetingNASDAQ:CNTBConnect Biopharma Holdings Inc
14/02/202312h33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNTBConnect Biopharma Holdings Inc
06/02/202314h30GlobeNewswire Inc.Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom CaliforniaNASDAQ:CNTBConnect Biopharma Holdings Inc
03/01/202322h32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNTBConnect Biopharma Holdings Inc
30/12/202213h30GlobeNewswire Inc.Connect Biopharma Provides Business and Clinical Development Program UpdateNASDAQ:CNTBConnect Biopharma Holdings Inc
19/12/202214h00GlobeNewswire Inc.Connect Biopharma to Present at the San Francisco Biotech Showcase in JanuaryNASDAQ:CNTBConnect Biopharma Holdings Inc
02/12/202223h00GlobeNewswire Inc.Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price RequirementNASDAQ:CNTBConnect Biopharma Holdings Inc
27/10/202222h05GlobeNewswire Inc.Connect Biopharma To Present at Upcoming Investor and Scientific ConferencesNASDAQ:CNTBConnect Biopharma Holdings Inc
05/10/202214h45TipRanksConnect Biopharma Holdings (CNTB) Receives a Buy from JefferiesNASDAQ:CNTBConnect Biopharma Holdings Inc
04/10/202214h56GlobeNewswire Inc.CORRECTING and REPLACING -- Connect Biopharma Reports CBP-201 Achieved All Primary and Key Secondary Endpoints in Pivotal Atopic Dermatitis (AD) Trial in ChinaNASDAQ:CNTBConnect Biopharma Holdings Inc
04/10/202213h00GlobeNewswire Inc.Connect Biopharma Reports CBP-201 Achieved All Primary and Key Secondary Endpoints in Pivotal Atopic Dermatitis (AD) Trial in ChinaNASDAQ:CNTBConnect Biopharma Holdings Inc
03/10/202222h10GlobeNewswire Inc.Connect Biopharma to Host a Conference Call Tuesday, October 4 to Discuss Topline Results for the Pivotal Trial in China of Lead Candidate, CBP-201, in Patients with Moderate-to-Severe Atopic DermatitisNASDAQ:CNTBConnect Biopharma Holdings Inc
13/09/202222h05GlobeNewswire Inc.Connect Biopharma Reports First Half 2022 Financial Results and Provides Business UpdateNASDAQ:CNTBConnect Biopharma Holdings Inc
01/09/202214h00GlobeNewswire Inc.Connect Biopharma to Report First Half 2022 Financial Results on September 13NASDAQ:CNTBConnect Biopharma Holdings Inc
30/08/202214h00GlobeNewswire Inc.Connect BioPharma Successfully Completes CBP-174 Phase 1 Single Ascending Dose StudyNASDAQ:CNTBConnect Biopharma Holdings Inc
14/07/202208h18TipRanksSVB Securities Thinks Connect Biopharma Holdings’ Stock is Going to RecoverNASDAQ:CNTBConnect Biopharma Holdings Inc
11/07/202222h05GlobeNewswire Inc.Connect Moves Forward CBP-201 Top-Line Results Timeline for Pivotal China Atopic Dermatitis Trial to Second Half 2022NASDAQ:CNTBConnect Biopharma Holdings Inc
07/07/202212h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNTBConnect Biopharma Holdings Inc
01/07/202223h13Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CNTBConnect Biopharma Holdings Inc
02/06/202222h05GlobeNewswire Inc.Connect Biopharma to Participate at the Jefferies Healthcare ConferenceNASDAQ:CNTBConnect Biopharma Holdings Inc
23/05/202212h02Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:CNTBConnect Biopharma Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CNTB

Dernières Valeurs Consultées

EU
ORA
Orange
EU
AI
Air Liquide
EU
BNP
BNP Paribas
EU
AF
Air FranceKLM
SPI
SP500
S&P 500
NYSE
DIS
Walt Disney
COIN
ETHUSD
Ethereum
NASDAQ
MSFT
Microsoft
EU
BEL20
Bel 20
NYSE
MCD
McDonalds
EU
PX4
SBF 120
EU
PX1
CAC 40
EU
BN
Danone
NYSE
NKE
Nike
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés